Rediff Logo
Money
Line
Channels: Astrology | Broadband | Chat | Contests | E-cards | Money | Movies | Romance | Search | Weather | Wedding
                 Women
Partner Channels: Auctions | Auto | Bill Pay | Jobs | Lifestyle | TechJobs | Technology | Travel
Line
Home > Money > Stocks > Corporate News
April 30, 2001
Feedback  
  Money Matters

 -  Business Special
 -  Business Headlines
 -  Corporate Headlines
 -  Columns
 -  IPO Center
 -  Message Boards
 -  Mutual Funds
 -  Personal Finance
 -  Stocks
 -  Tutorials
 -  Search rediff

    
      



 

 Novartis signs Letter of Intent for sale of property
 Novartis India Ltd has informed BSE that the company together with Ciba Specialty Chemicals India Ltd. has signed a Letter of Intent with Kingston Properties Pvt Ltd for sale of their rights and interest in certain properties situated at Goregaon.
The parties have agreed to execute a Memorandum of Understanding (MOU) on satisfaction of certain pre-conditions. On execution of this MOU the company will receive consideration of Rs 725 million in installments over a period of 4 years.

 Ciba Specialty Chem signs Letter of Intent for sale of property
 Ciba Specialty Chemicals India Ltd has informed BSE that the company together with Novartis India Ltd has signed today (April 30, 2001) a Letter of Intent with Kingston Properties Private Ltd for the intended sale of its rights sale of its rights and interests in certain land situated at Goregaon (East) subject to the conditions therein specified.
An agreement for sale and transfer of its aforesaid rights and interests will be entered into by Ciba with Kingston Properties Private Ltd and Novartis India Ltd upon satisfaction of the conditions specified in the letter of intent. If the above agreement for sale is executed then the sale consideration payable by Kingston Properties Private Ltd to Ciba will be Rs 203 million.

 Bombay Dyeing FY-01 results by June 30, 2001
 Bombay Dyeing & Manufacturing Co Ltd has informed BSE that the company will publish audited accounts for the year ended March 31, 2001 on or before June 30, 2001. Since the company will be publishing the audited financial results for the year ended March 31, 2001 the company will not publish unaudited results for the quarter ended March 31, 2001.

 Essel Packaging to publish FY-01 results by May 31, 2001
 Essel Packaging Ltd has informed BSE that the company will publish audited accounts for the year ended March 31, 2001 on or before May 31, 2001.

 Britannia FY-01 results by June 30, 2001
 Britannia Industries Ltd has informed BSE that the company will publish audited accounts for the year ended March 31, 2001 on or before June 30, 2001. Since the company will be publishing the audited financial results for the year ended March 31, 2001 the company will not publish unaudited results for the quarter ended March 31, 2001.

 Reliance Capital fixes Book Closure for dividend
 Reliance Capital limited has informed BSE that the company has fixed Book Closure from June 01, 2001 to June 16, 2001 for payment of dividend.The Board of Directors at its meeting held today (April 30, 2001) recommended a dividend of 29% on equity shares for the year ended March 31, 2001

 Suven Pharma allots shares on preferential basis
 The Board of Directors of Suven Pharmaceuticals Ltd at its meeting held today (April 30, 2001) has allotted 0.40 million equity shares of Rs 10 each at a premium of Rs 240 per share to M/s Borregaard Industries Ltd of Norway in accordance with the SEBI guidelines relating to preferential offers.

 Shipping Corp Q4 net up by 55.33%, FY-01 net up by 148.49%
 Shipping Corporation of India Ltd has posted a net profit of Rs 1694.40 million in the quarter ended March 31, 2001 as compared to Rs 1090.80 million in the corresponding period last fiscal. Total income posted is at Rs 9175.90 million in the quarter ended March 31, 2001 as compared to Rs 7300.80 million in the quarter ended March 31, 2000. The Company has posted a net profit of Rs 4015.90 million in FY-01 as compared to Rs 1616.10 million in FY-00. Total income is at Rs 32088.80 million in the year ended March 31, 2001 as compared to Rs 26147.50 million in the corresponding period last fiscal.

 Supreme Industries Q3 net down by 91.31%
 Supreme Industries Ltd has posted a net profit of Rs 3.06 million for the quarter ended March 31, 2001 as compared to Rs 35.24 million in MQ 2000. Total Income for the quarter ended March 31, 2001 is at Rs 1357.57 million as compared to Rs 1463.40 million in the quarter ended March 31, 2000.
The business conditions have improved since March. This was principally due to success achieved by the Company on various cost cutting initiatives and reduction in raw material prices. The company has also undertaken manpower reduction programme in its various plants and offices which will reduce the strength from 1765 nos as on 01.04.2001 by 180 people by September 2001.
The Company has incurred capital expenditure in excess of Rs 520 million. The increased investment was required to strengthen range of furniture and crates in newly commissioned five manufacturing sites and to commission a new facility to manufacture industrial components for an MNC. This has increased interest burden in the year.

 Videocon Int Q4 net up by 66.98%, FY-01 net up by 7.38%
 Videocon International Ltd has posted a net profit of Rs 424.80 million in the quarter ended March 31, 2001 as compared to Rs 254.40 in the quarter ended March 31, 2000. Total Income is at Rs 9066.70 million for the quarter ended March 31, 2001 as compared to Rs 7238.20 million in the corresponding period last fiscal.
The Company has posted a net profit of Rs 1514.40 million in the year ended March 31, 2001 as compared to Rs 1410.30 million in the year ended March 31, 2000. Total income posted is at Rs 32537 million in FY-01 as compared to Rs 30048.30 million in FY-00.

 Flat Products Q4 net profit at Rs 23.20 million, FY-01 net at Rs 60.12 million
 Flat Products Equipment (India) Ltd. net profit for the quarter ended March 31, 2001 is at Rs 23.20 million as compared to a net loss of Rs 52.07 million in the quarter ended March 31, 2000. Total income is at Rs 626.06 million for the quarter ended March 31, 2001 as compared to Rs 296.94 million in the corresponding period last fiscal.
Net profit for the year ended March 31, 2001 is at Rs 60.12 million as compared to a net loss of Rs 46.81 million in the year ended March 31, 2000. Total income for the year ended March 31, 2001 is at Rs 1277.98 million as compared to Rs 1013.56 million in FY-00.

 KRBL Q4 net dips by 67.58%, FY-01 net falls by 28.75%
 KRBL Ltd net profit has fallen from Rs 47.20 million in the quarter ended March 31, 2000 to Rs 15.30 million in the quarter ended March 31, 2001. Total Income is at Rs 736.40 million for the quarter ended March 31, 2001 as compared to Rs 793.80 million in the corresponding period last fiscal.
Net Profit has fallen from Rs 149.90 million in the year ended March 31, 2000 to Rs 106.80 million in the year ended March 31, 2001. Total Income for FY-01 is at Rs 2613.20 million as compared to Rs 2201.70 million in the corresponding period last fiscal.

 Mascon Global Q1 net up by 85.49%
 Mascon Global Ltd has posted a net profit of Rs 220 million for the quarter ended March 31, 2001 as compared to Rs 118.60 million for the quarter ended March 31, 2000. Total Income for the quarter ended March 31, 2001 is at Rs 1071.60 million as compared to Rs 611.80 million in the quarter ended March 31, 2000.

 Dr Reddy's contracts clinical trials of DRF 4832 to Simbec
 Dr Reddy's Laboratories Ltd. has informed BSE that as a first step towards taking its molecules through clinical development on its own, the Company has selected Simbec Research Ltd., a well-known UK-based Clinical Research Organization (CRO), for conducting clinical trials of DRF 4832.
DRF 4832 is a PPAR agonist for treatment of cardiovascular complications. Dr. Reddy's is developing this molecule by modulating two risk factors namely low HDL (beneficial cholesterol) and elevated triglycerides levels.
Simbec will shortly take up regulatory toxicology studies of DRF 4832.
Dr, Reddy's has been licensing its molecules to multinational companies for further development, after completing preclinical studies. DRF-2725 and DRF-2593 are two such molecules in the anti-diabetes area that are currently in late Phase II clinical development.

 Gati Q3 net falls by 88.16%
 Gati Ltd.net profit has fallen from Rs 24.5 million in the quarter ended March 31, 2000 to Rs 2.9 million in the quarter ended March 31, 2001. Total Income is at Rs 634.60 million in the quarter ended March 31, 2001 as compared to Rs 558.90 million in the corresponding period last fiscal.
The Company has invested over Rs 17.50 million during the period for the first time towards Brand Building.
The Company has also invested over Rs 24.70 million towards Online Tracking System for ensuring excellence in Customer Service.
There has been an increase in Share Capital from Rs 55.70 million to Rs 83.60 million is on account of allotment of 27,85,500 Bonus Equity Shares on October 26, 2000 in the ratio of One Equity Share for Two Shares held by the Shareholders (Rs 27.90 million).

 Lakshmi Precision Q4 net down by 29.45%, FY-01 net down by 9.69%
 Lakshmi Precision Screws Ltd. net profit has fallen from Rs 11.90 million in MQ 2000 to Rs 8.39 million in the quarter ended March 31, 2001. Total income for the quarter ended March 31, 2001 is at Rs 227.90 million as compared to Rs 230 million in the corresponding period last fiscal.
Net profit has fallen from Rs 32.17 million in the year ended March 31, 2000 to Rs 29.05 million in the year ended March 31, 2001. Total income for FY-01 is at Rs 845.56 million as compared to Rs 822.78 million in FY-00.

 Reliance Capital Q4 net up by 1.66%, FY-01 net up by 3.19%
 Reliance Capital Ltd has posted a net profit of Rs 275 million for the quarter ended March 31, 2001 as compared to Rs 270.50 million in the corresponding period last fiscal. Total Income for the quarter ended March 31, 2001 is at Rs 1297 million as compared to Rs 1244.10 million in MQ 2000.
Net profit for the year ended March 31, 2001 is at Rs 934.50 million as compared to Rs 905.60 million in FY-00. Total Income for the year ended March 31, 2001 is at Rs 4922 million as compared to Rs 4574 million in the corresponding period last fiscal.
The Board of Directors of the company at its meeting held today (April 30, 2001) has recommended a dividend of 29% for the year ended March 31, 2001 on equity shares.

 Gillette revises Book Closure for dividend
 Gillette India Ltd. has informed BSE that the Board of Directors has on their meeting held on April 24, 2001, revised the date of the Annual General Meeting from June 27, 2001 to June 28, 2001. Consequently, the Register of Members and Share Transfer Books shall remain closed from June 25, 2001 to June 28, 2001. Dividend shall be paid to shareholders whose names appear on Register of Members as on June 28, 2001.

 South East Asian Marine Q1 net loss lower by 77.71%
 South East Asian Marine Engineering & Construction Ltd has posted a net loss of Rs 11.30 million for the quarter ended March 31, 2001 as compared to a net loss Rs 50.70 million in the quarter ended March 31, 2000. Total income has fallen from Rs 235.60 million in the quarter ended March 31, 2000 to Rs 203.30 million in the quarter ended March 31, 2001.

 Atlas Copco Q1 net at Rs 46.10 million
 Atlas Copco (I) Ltd. has posted a net profit of Rs 46.10 million in the quarter ended March 31, 2001 as compared to Rs 17.60 million in the quarter ended March 31, 2000. Total income for the quarter ended March 31, 2001 is at Rs 634.80 million as compared to Rs 274.60 million in the corresponding period last fiscal.
The figures for the first quarter ended March 31, 2001 are for the merged entity and included the results of operations of the erstwhile Chicago Pneumatic India Ltd.(CPIL), and are therefore, not comparable to the corresponding figures for the quarter ended March 31, 2000.

 Saregama Q4 net loss at Rs 18.20 million, FY-01 net falls by 10.31%
 Saregama India Ltd. has posted a net loss of Rs 18.20 million in the quarter ended March 31, 2001 as compared to a net profit of Rs 27.90 million in the quarter ended March 31, 2000. Total income for the quarter ended March 31, 2001 is at Rs 480.90 million as compared to Rs 507.60 million in the corresponding period last fiscal.
Net profit for has fallen from Rs 60.10 million in the year ended March 31, 2000 to Rs 53.90 million in FY-01. Total income is at Rs 1770.40 million for the year ended March 31, 2001 as compared to Rs 1460.90 million in the corresponding period last fiscal.

 BSE revises special margin on 22 scrips
 BSE has informed members of the exchange that the following scrips which are at present under Special Margins will attract Special Margins as indicated hereunder with effect from Monday April 30 2001 The rates of Special Margins have been revised keeping in view the closing price of the scrip on the last day of the settlement. CODE NAME GROUP SPECIAL MARGIN
410 A C C A 25
12599 ADANI EXPORTS A 25
31632 AVINASH INFORM B2 25
24170 DSQ BIOTECH B2 50
23864 DSQ SOFTWARE A 25
300 GRASIM INDUSTRY A 25
31984 GUJARAT FISCON B2 50
183 HIMACHAL FUTURI A 25
888 JAIPRAKASH INDS A 25
32127 MOBILE TELE B2 25
32279 RSL INDUS B2 25
32118 SAI INFO.SERVIC B2 50
378 SAW PIPES A 25
17411 SHYAM TELECOM A 25
32274 SOFFIA SOFTWARE B2 25
32221 SONATA SOFTWARE A 25
31830 TODAY'S WRITING B2 25
26707 TOUBRO INFOTECH B2 50
32035 UNISTAR MULTI B2 25
32325 VITAL COMM B2 25
32300 WOCKHARDT A 25
31404 ZICOM ELECT B2 25

 Grasim Q4 net up by 203.83%, FY-01 net up 62.11%
 Grasim Industries Ltd has posted a net profit of Rs 1449.60 million for the quarter ended March 31, 2001 as compared to Rs 477.10 million in the corresponding period last fiscal. Net sales for the quarter ended March 31, 2001 are at Rs 1262.70 million as against Rs 1101.20 million in the quarter ended March 31, 2000.
Net profit for the year ended March 31, 2001is at Rs 3779 million as compared to Rs 2331 million in FY-00. Net Sales for the year ended March 31, 2001 is at Rs 48398 million as compared to Rs 42897 million in the corresponding period last fiscal.
The capacity utilization in the cement plants during the year was at 100%. Sales volumes at 9.16 million MT were higher by 8.79% over that of the last year.
Considering the excellent results posted for the year under review, the Board of Directors has, at its meeting held on April 30, 2001, recommended a dividend of 80% (as compared to last years 70%) aggregating Rs 733.40 million.
Three major factors have contributed to Grasim's sterling performance. These are, firstly, an all round growth by way of heightened production and turnover along with higher realizations: secondly, savings in operating costs resulting from the ongoing modernisation efforts, up-gradation of plants and energy optimization: and thirdly, reduction in financing cost through restructuring of high cost debts coupled with effective fund management and reduction of costs.

 Reliance Industries Board approves hike in FII limit to 49%
 Reliance Industries Ltd has informed BSE that the Board of Directors at its meeting held today (April 30, 2001) approved inter alia the following matters subject to the approval of the shareholders at the ensuing Annual General Meeting which is scheduled to be held on June 15, 2001.
1) The Company's existing share buyback programme is valid upto June 12, 2001.In accordance with applicable laws, the Board has proposed to extend the programme for buyback of equity shares for the year 2001-2002, for an amount not exceeding Rs 11000 million and upto a maximum price of Rs 303 per share.
2) Increase in the limit for investment in Equity shares of the Company by Foreign Institutional Investors (FIIs), from the existing 24% to 49% of the paid up Equity Share capital of the Company.
3) Enabling resolution for voluntary delisting of Equity Shares from certain Stock Exchanges.

 Strike at Sesa Goa
 Sesa Goa Ltd has informed BSE that the employees of the company have restored to an illegal strike adversely affecting the normal activities of the company since April 17, 2001. This will have an adverse impact on the working of the company.

 Licensing Income helps Ranbaxy post 46.80% rise in Q1 net profit
 Ranbaxy Laboratories Ltd has posted a net profit of Rs 574 million for the quarter ended March 31, 2001 as compared to Rs 391 million for the quarter ended March 31, 2000. Total income for the quarter ended March 31, 2001 is at Rs 4621 million as compared to Rs 4016 million in the corresponding period last fiscal.
The company has earned a technology licensing income of Rs 233 million for the quarter ended March 31, 2001.

 VSNL Q4 net up by 43.41%, FY-01 net up by 87.74%
 Videsh Sanchar Nigam Limited net profit is at Rs 4473 million for the quarter ended March 31, 2001 as compared to Rs 3119 million in the corresponding period last fiscal. Total income is at Rs 21383 million for the quarter ended March 31, 2001 as compared to Rs 20215 million in the quarter March 31, 2000.
Net profit for the year ended March 31,2001 is at Rs 15776 million as compared to Rs 8403 million in FY-00. Total income is at Rs 78765 million in FY-01 as compared to Rs 73237 million in the corresponding period last fiscal.

 ACC FY-01 net at Rs 571.70 million
 Associated Cement Companies Ltd has posted a net profit of Rs 571.70 million for the year ended March 31, 2001 as compared to a net loss of Rs 588.50 million for the year ended March 31, 2000. Total Income for the year ended March 31, 2001 is at Rs 26491 million as compared to Rs 23820 million in the corresponding period last fiscal.
Clinker production of 8.21 million tonnes for the year was marginally higher as compared to the previous year. Production of Cement for the year was 10.21 million tonnes as compared to 10.04 million tonnes in the previous year, registering an increase of 2%. Sale of Cement during the year excluding traded product aggregated to 10.24 million tonnes as compared to 9.95 million tonnes in the previous year. Sale of traded cement was 0.82 million tonne as compared to 0.78 million tonne in the previous year.
The Board of Directors of the Company has decided to recommend a dividend of Rs 2 per share aggregating to Rs 376.2 million (including tax on dividend).

 Century Textiles FY-01 net up by 56.28%
 Century Textiles and Industries Ltd. net profit for the year ended March 31, 2001 is at Rs 539.5 million as compared to Rs 345.20 million in FY-00. Total income is at 23589.90 million for the year ended March 31, 2001 as compared to Rs 21960.90 million in the corresponding period last fiscal.
The Board of Directors has recommended dividend @ 10% on paid up equity Share Capital of the Company for the year ended March 31, 2001 as against 6% paid in the previous year.

 Reliance Q4 net down by 17.43%, FY-01 net up by 10.11%
 Reliance Industries Ltd has posted a net profit of Rs 5400 million for the quarter ended March 31, 2001 as compared to Rs 6540 million for the corresponding period last fiscal. Total Income for the quarter ended March 31, 2001 is at Rs 60780 million as compared to Rs 61870 million in the corresponding period last fiscal.
The net profit for the year ended March 31, 2001 is at Rs 26460 million as compared to Rs 24030 million in the corresponding period last fiscal. Total Income for the year ended March 31, 2001 is at Rs 258120 million as compared to Rs 185260 million in the financial year ended March 31, 2000.
The Board of Directors has recommended a dividend of 42.5% (Rs 4.25 per share) for the year ended March 31, 2001.

 Knoll Pharma Q1 net down by 22.53%
 Knoll Pharmaceuticals Ltd. net profit has fallen from Rs 118.50 million in the quarter ended March 31, 2000 to Rs 91.80 million in the quarter ended March 31, 2001. Total income is at Rs 837.80 million in the quarter ended March 31, 2001 as compared to Rs 765.20 million in the corresponding period last fiscal.
The results for the quarter ended 31st March 2001 have been adversely affected due to price reduction in some formulations and delay in getting compensatory price increase in some price controlled formulations.

 Reliance Petroleum FY-01 net at Rs 14640 million, approves hike in FII limit to 49%
 Reliance Petroleum Ltd has posted a net profit of Rs 2970 million for the quarter ended March 31,2001 on a total income of Rs 75720 million for the quarter ended March 31, 2001.
The net profit for the year ended March 31, 2001 is at Rs 14640 million. Total income for the FY-01 is at Rs 311830 million.
The Board of Directors of the Company has recommended dividend of 5%.
Further, the Board has also approved the proposal for investment by Foreign Institutional investors (FIIs) up to 49% of the paid up equity share capital of the Company.

 Emerging Markets Growth Fund holding in Infosys at 5.15%
 Infosys Technologies Ltd has informed BSE that the company has received a disclosure from Emerging Markets Growth Fund Inc stating that they hold 34,04,880 equity shares representing 5.15% of the paid up capital of the company.

 MRF Q2 net down by 74.77%
 MRF Ltd. net profit has fallen from Rs 166.50 million in the quarter ended March 31, 2000 to Rs 42 million in the quarter ended March 31, 2001. Total income is at Rs 4303.40 million in the quarter ended March 31, 2001 as compared to Rs 4440.70 million in the corresponding period last quarter.

 Kesoram Ind to consider buy back of equity shares
 A meeting of the Board of Directors of Kesoram Industries Ltd has been convened on May 04, 2001 inter alia to consider
1. the feasibility of but back of ordinary shares of the company
2. Reports of Price Water House on merger proposal of Birla Century Finance Ltd and Hindustan Heavy Chemicals Ltd. with the company.

 Jaiprakash Ind. appoints Ravi Rajagopal as Company Secretary
 Jaiprakash Industries Ltd. has informed BSE that Mr. Ravi Rajagopal has been appointed as company Secretary of the Company with effect from April 26, 2001. In terms of clause 45(a) of the Listing agreement, Mr Ravi Rajagopal shall be the Compliance Officer of the Company with effect from April 26, 2001.
Mr. Harish Vaid Jt President (Corporate Affairs) & Company Secretary has been promoted as Sr Jt President (Corporate Affairs).

 Raymond completes buy-back programme
  Raymond Ltd. has informed BSE that the Company has discontinued scheme of buyback of its fully paid-up equity shares of face value Rs 10 each from the Open Market through the trading mechanism of the Exchange with effect from April 30, 2001. The company has bought back 1,37,10,083 shares from the open market for a total consideration of Rs.1862.5 million.
The company had fixed an amount not exceeding Rs 1869.40 million for the purpose of buy-back.

 SSI Q3 net up by 67.66%
 SSI Ltd. net profit for the quarter ended March 31, 2001 is at Rs 176.09 million as compared to Rs 105.03 million in the quarter ended March 31, 2000. Total Income for the quarter ended March 31, 2001 is at Rs 1054.81 million as compared to Rs 539.55 million in the corresponding period last fiscal.
During the quarter M/s Albion Orion Company, LLC (AOC), the Wholly Owned Subsidiary of SSI, transferred intangible assets valued at US$ 51.381 million to SSI as part of the capital restructuring by AOC.
Consequent to restructuring of the line of business within the organisation, the management has decided to discontinue the operations of Enterprise Support division with effect from April 1, 2001.

 Supreme Industries to consider issuance of OCDs
 The Board of Directors of Supreme Industries Ltd at its meeting scheduled on April 30, 2001 will consider the unaudited working results of the company for the third quarter ended March 31, 2001.
The Board of Directors at the aforesaid meeting will consider issuance in one or more steps upto 1 million OCDs (Optionally Covertible Debentures) of Rs 500 face value each, partially convertible in two equity shares for each OCD, one share at the end of 18 months and another share at the end of 36 months form the date of allotment of OCDs at such respective premium (over the face value) as may be decided by the Board, bearing the rate of interest and other terms and conditions as the Board may decide.

 Adlabs Films Q4 net up by 71.96%, FY-01 net up by 122.95%
 Adlabs Films Ltd has posted a net profit of Rs 40.15 million for the quarter ended March 31, 2001 as compared to Rs 23.35 million in the corresponding period last fiscal. Total Income for the quarter ended March 31, 2001 is at Rs 139.19 million as against Rs 110.43 million in MQ 2000.
Net Profit for the year ended March 31, 2001 is at Rs 115.43 million as compared to Rs 51.77 million in the financial year ended March 31, 2000. Total Income for the year ended March 31, 2001 is at Rs 491.60 million as compared to Rs 368.32 million in the corresponding period last fiscal.
The IMAX Adlabs Dome theatre has been commissioned on March 25, 2001 and is open for public.

 Novartis shareholders approve amalgamation of Ciba CKD
 Novartis India Limited has informed BSE that the shareholders of the company and Ciba CKD Biochem Ltd. have approved of the amalgamation of Ciba CKD Biochem Ltd. with the company.

 Pantaloon Board approves conversion of warrants into equity shares
 Pantaloon Industries Ltd. has informed BSE that the Board of Directors of the Company has approved conversion of 0.8 million warrants into equity shares of the company at a premium of Rs.41/- per share.

 Global Trust Q4 net loss at Rs 227.10 million, FY-01 net down by 26.04%.
 Global Trust Bank Ltd. net loss for the quarter ended March 31, 2001 is at Rs 227.10 million as compared to a net profit of Rs 353.3 million in the quarter ended March 31, 2000. Total Income has fallen from Rs 3088.10 million in the quarter ended March 31, 2000 to Rs 3010.60 million in the quarter ended March 31, 2001.
Net Profit has fallen from Rs 1086.20 million in the year ended March 31, 2000 to Rs 803.30 million in the year ended March 31, 2001. Total Income is at Rs 10619.40 million for the year ended March 31, 2001 as compared to Rs 8791.20 million in the corresponding period last fiscal.
The Board of Directors of the Company has recommended dividend of Rs 1.5 per share i.e. at 15%.

 Toubro Infotech Board approves increase in authorised capital
 Toubro Infotech & Industries Ltd. has informed BSE that the Board of Directors of the Company has approved as under, subject to necessary approvals:
1. Increase in authorised share capital from Rs.60 million to Rs.200 million.
2. Allotment of Redeemable Preference shares subject to maximum amount of Rs.100 million to the existing promoters.
3. Change in name of the company to Toubro Ltd.
4. EGM of the company will be held on May 31, 2001.

Money

Rapid Information on Stocks & Corporates

Tell us what you think of this report